Axsome Therapeutics, Inc. (AXSM)
219.15
-3.48
(-1.56%)
USD |
NASDAQ |
May 07, 12:01
Axsome Therapeutics SG&A Expense (TTM) : 449.81M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Merck & Co., Inc. | 10.88B |
| Madrigal Pharmaceuticals, Inc. | 645.95M |
| Insmed, Inc. | 701.17M |
| AnaptysBio, Inc. | 50.74M |